Nymox Pharmaceutical: Assessing The Short And Long Ideas [Seeking Alpha]
![Seeking Alpha](../../../Content/images/providers/Seeking Alpha.png)
Nymox Pharmaceutical Corporation (NYMX)
US:NASDAQ Investor Relations:
nymox.com/default.action?itemid=3
Company Research
Source: Seeking Alpha
Nymox Pharmaceutical: Assessing The Short And Long Ideas Nymox Pharmaceutical ( NYMX article That article took the stock down by almost 50%, however, it quickly recovered in the same month to soar back to above where it was before the fall. Couple more short articles followed over the years. Some people, I am sure, made money during that fall and rise. Then last year, in February, we had another author named Stan Piland publish a bullish “I expect approval in five European countries (France, Germany, Netherlands, Spain, and UK) within the next few months,” - he wrote - “followed by approval in the U.S. and the rest of the EU in mid-late 2019. Once approved, Fexapotide can be a blockbuster drug….This analysis shows that when approved in Europe and the U.S., just 10%-15% market penetration at $3,000 per dose yields $6.5-$9.7 billion in peak revenues, likely achievable within 5 years.” That did not happen. Fexapotide was not approved in those countries within the next few months. Nor is
Show less
Read more
Impact Snapshot
Event Time:
NYMX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NYMX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NYMX alerts
High impacting Nymox Pharmaceutical Corporation news events
Weekly update
A roundup of the hottest topics